Sham Mask

DEVICE3 trials

Sponsors

Johnson & Johnson Consumer Inc. (J&JCI), Azienda Ospedaliera Universitaria Mater Domini, Catanzaro, TriHealth Inc.

Conditions

Age-Related Macular DegenerationNeurogenic BladderOveractive BladderPainPelvic Floor DisordersSkin AgingUrge IncontinenceUrinary Bladder Neurogenesis

Phase 4

A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections

Not yet recruitingNCT07387315

TriHealth Inc.Neurogenic Bladder, Overactive Bladder, Pain +7

Start: 2026-02-01End: 2026-12-01Target: 96Updated: 2026-02-04

Unknown Phase

Evaluation of the Efficacy and Tolerance of a Light Therapy Mask on Mild to Moderate Brown Spots and Moderate to Severe Facial Wrinkles

CompletedNCT03312543

Johnson & Johnson Consumer Inc. (J&JCI)Skin Aging

Start: 2017-10-09End: 2018-04-06Updated: 2019-03-05

Photobiomodulation in Dry Age Related Macular Degeneration

RecruitingNCT06046118

Azienda Ospedaliera Universitaria Mater Domini, CatanzaroAge-Related Macular Degeneration

Start: 2023-04-01End: 2024-12-31Target: 180Updated: 2024-09-19

Related Papers

Safety, Tolerability, and Short-Term Efficacy of Low-Level Light Therapy for Dry Age-Related Macular Degeneration.

2024-09-1310 citations